Michael Heffernan

Michael Heffernan

DirectoratenGene Therapeutics· In the 2025 proxy

Michael Heffernan sits on 6 public boards.

Boards1

  • enGene TherapeuticsDirector · 0 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. enGene TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role -82%
  2. Avalo TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  3. Biohaven Ltd.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  4. Trevi TherapeuticsPublic company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  5. Synlogic, Inc.Public company · 5 yr
    • Director2020 – 2025 · 5 yrNo stock prices for these years
  6. Akebia Therapeutics, Inc.Public company · 4 yr
    • Director2018 – 2022 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?